The consumer regulator asked a court Friday to dismiss a lawsuit brought against it by Chinese vitamin giant Nature’s Care Manufacture over Australian-made product labels, saying it had been wrongly “dragged into a controversy”.
Liquidators for failed engineering services company Hastie Group have a fight on their hands over tens of millions of dollars in unpaid invoices from construction companies, with major builders claiming not only that they don’t have to pay, but that the bills aren’t payable.
A judge will appoint an independent barrister to examine Westpac’s recent $35 million settlement with the corporate regulator, saying it wasn’t clear if the bank had breached responsible lending laws as alleged.
The ABC and Fairfax Media are appealing a ruling tossing their truth defence in a case brought by Chinese billionaire and philanthropist Dr Chau Chak Wing.
A gamer has admitted he violated the copyright for Take-Two Interactive’s popular Grand Theft Auto video game by making unauthorised changes to the game that allowed him to manipulate the actions of other online players without their consent.
The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.
A Federal Court judge has put an appeal by Aristocrat of an IP Australia ruling that revoked four of its gaming patents on hold pending the outcomes of two highly anticipated cases over the patentability of computer software.
Confectionery giant Mars has successfully opposed an application by Kraft Foods for an Australian patent for chocolate that doesn’t melt in the summer months.
A native title challenge to Adani Mining’s controversial $16 billion development of the Carmichael coal mine in Queensland has been revived, with a group of Indigenous Australians appealing a ruling that tossed their case.
Animal drug giant Merial is pushing on with its opposition to rival Intervet’s bid to a patent a non-drug resistant injectable formula for treating animal parasites, filing an appeal in the Federal Court after it came up short in its challenge before IP Australia.